4.3 Article

The nursing home elder microbiome stability and associations with age, frailty, nutrition and physical location

期刊

JOURNAL OF MEDICAL MICROBIOLOGY
卷 67, 期 1, 页码 40-51

出版社

MICROBIOLOGY SOC
DOI: 10.1099/jmm.0.000640

关键词

intestinal microbiome; nursing home; elderly; frailty; malnutrition; physical location

资金

  1. Department of Emergency Medicine
  2. Center for Microbiome Research at the University of Massachusetts Medical School
  3. National Institute on Aging [1R03AG056356-01]
  4. NIH [1R15AI112985-01A1]
  5. Div Of Biological Infrastructure
  6. Direct For Biological Sciences [1458347] Funding Source: National Science Foundation

向作者/读者索取更多资源

Purpose. The microbiome from nursing home (NH) residents is marked by a loss in diversity that is associated with increased frailty. Our objective was to explore the associations of NH environment, frailty, nutritional status and residents' age to microbiome composition and potential metabolic function. Methodology. We conducted a prospective longitudinal cohort study of 23 residents, 65 years or older, from one NH that had four floors: two separate medical intensive floors and two floors with active elders. Residents were assessed using the mini nutritional assessment tool and clinical frailty scale. Bacterial composition and metabolic potential of residents' stool samples was determined by metagenomic sequencing. We performed traditional unsupervised correspondence analysis and linear mixed effect modelling regression to assess the bacteria and functional pathways significantly affected by these covariates. Results/Key findings. NH resident microbiomes demonstrated temporal stability (PERMANOVA P=0.001) and differing dysbiotic associations with increasing age, frailty and malnutrition scores. As residents aged, the abundance of microbiotaencoded genes and pathways related to essential amino acid, nitrogenous base and vitamin B production declined. With increasing frailty, residents had lower abundances of butyrate-producing organisms, which are associated with increased health and higher abundances of known dysbiotic species. As residents became malnourished, butyrate-producing organisms declined and dysbiotic bacterial species increased. Finally, the microbiome of residents living in proximity shared similar species and, as demonstrated for Escherichia coli, similar strains. Conclusion. These findings support the conclusion that a signature 'NH' microbiota may exist that is affected by the residents' age, frailty, nutritional status and physical location.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

Takeshi Tanoue, Satoru Morita, Damian R. Plichta, Ashwin N. Skelly, Wataru Suda, Yuki Sugiura, Seiko Narushima, Hera Vlamakis, Iori Motoo, Kayoko Sugita, Atsushi Shiota, Kozue Takeshita, Keiko Yasuma-Mitobe, Dieter Riethmacher, Tsuneyasu Kaisho, Jason M. Norman, Daniel Mucida, Makoto Suematsu, Tomonori Yaguchi, Vanni Bucci, Takashi Inoue, Yutaka Kawakami, Bernat Olle, Bruce Roberts, Masahira Hattori, Ramnik J. Xavier, Koji Atarashi, Kenya Honda

NATURE (2019)

Article Microbiology

Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway

John P. Haran, Shakti K. Bhattarai, Sage E. Foley, Protiva Dutta, Doyle V. Ward, Vanni Bucci, Beth A. McCormick

Article Hematology

Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients

Matthew S. Kelly, Doyle V. Ward, Christopher J. Severyn, Mehreen Arshad, Sarah M. Heston, Kirsten Jenkins, Paul L. Martin, Lauren McGill, Andre Stokhuyzen, Shakti K. Bhattarai, Vanni Bucci, Patrick C. Seed

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Review Engineering, Environmental

Fresh Ideas Bloom in Gut Healthcare to Cross-Fertilize Lake Management

Ferdi L. Hellweger, Carsten Vick, Fiona Rueckbeil, Vanni Bucci

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2019)

Article Chemistry, Medicinal

Microcin H47: A Class IIb Microcin with Potent Activity Against Multidrug Resistant Enterobacteriaceae

Jacob D. Palmer, Benedikt M. Mortzfeld, Emma Piattelli, Mark W. Silby, Beth A. McCormick, Vanni Bucci

ACS INFECTIOUS DISEASES (2020)

Article Hematology

Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

John Tanaka, Rebecca Young, Sarah M. Heston, Kirsten Jenkins, Lisa Spees, Anthony D. Sung, Kelly Corbet, Jillian C. Thompson, Lauren Bohannon, Paul L. Martin, Andre Stokhuyzen, Richard Vinesett, Doyle Ward, Shakti K. Bhattarai, Vanni Bucci, Mehreen Arshad, Patrick C. Seed, Matthew S. Kelly

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Article Gastroenterology & Hepatology

Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease

John P. Haran, Beth A. McCormick

Summary: The human gut microbiome, consisting of bacteria, protozoa, fungi, and viruses, plays essential roles in protecting, metabolizing, and maintaining human health. Imbalances within the intestinal microbial community structure are increasingly recognized as being involved in disease processes across various organ systems, particularly due to untoward inflammatory responses. Recent advances in understanding the microbiome's role in aging have opened the door for potential novel therapeutics targeting a less dysbiotic microbiome to prevent or treat age-related diseases.

GASTROENTEROLOGY (2021)

Letter Medicine, Research & Experimental

Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study

John P. Haran, Jose C. Pinero, Yan Zheng, Norma Alonzo Palma, Mark Wingertzahn

Summary: The two parallel studies aim to evaluate the safety and impact of KB109 in addition to supportive self-care compared to self-care alone in outpatients with mild to moderate COVID-19. These studies also assess the effect of KB109 on gut microbiota and various health indicators in patients receiving different treatment regimens.

TRIALS (2021)

Article Medicine, Research & Experimental

Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID

John P. Haran, Evan Bradley, Abigail L. Zeamer, Lindsey Cincotta, Marie-Claire Salive, Protiva Dutta, Shafik Mutaawe, Otuwe Anya, Mario Meza-Segura, Ann M. Moormann, Doyle Ward, Beth A. McCormick, Vanni Bucci

Summary: In a study, it was found that patients with long COVID had higher abundance of bacteria in the oral microbiome that can induce inflammation, such as Prevotella and Veillonella genera. These microbes may be related to the development of ongoing symptoms in patients, and the oral microbiome of long COVID patients resembled that of patients with chronic fatigue syndrome.

JCI INSIGHT (2021)

Article Cell Biology

Proanthocyanidin-enriched cranberry extract induces resilient bacterial community dynamics in a gnotobiotic mouse model

Catherine C. Neto, Benedikt M. Mortzfeld, John R. Turbitt, Shakti K. Bhattarai, Vladimir Yeliseyev, Nicholas DiBenedetto, Lynn Bry, Vanni Bucci

Summary: Cranberry consumption has health benefits including anti-inflammatory and anti-tumor properties. Research suggests that the effects of cranberry on health could be related to its ability to modulate the microbiome, but more studies are needed to investigate the impact, especially regarding PACs. The study on the short-term dynamics of a human-derived bacterial community after a PAC-rich cranberry juice extract intervention showed distinct dynamic patterns in bacterial abundances, indicating that termination of the intervention can induce significant changes in the microbiota.

MICROBIAL CELL (2021)

Article Gastroenterology & Hepatology

Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study

Barbara Olendzki, Vanni Bucci, Caitlin Cawley, Rene Maserati, Margaret McManus, Effie Olednzki, Camilla Madziar, David Chiang, Doyle Ward, Randall Pellish, Christine Foley, Shakti Bhattarai, Beth A. McCormick, Ana Maldonado-Contreras

Summary: This study aims to investigate the impact of specific foods on the intestinal microbiome in patients with IBD and explore the interactions between diet and immunity to provide personalized nutrition guidance for IBD patients with dysbiosis-related conditions.

GUT MICROBES (2022)

Article Gastroenterology & Hepatology

Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic

Benedikt M. Mortzfeld, Jacob D. Palmer, Shakti K. Bhattarai, Haley L. Dupre, Regino Mercado-Lubio, Mark W. Silby, Corinna Bang, Beth A. McCormick, Vanni Bucci

Summary: This study discovered a potent antimicrobial called MccI47 against specific drug-resistant bacteria. The researchers genetically modified the probiotic Escherichia coli bacterium to produce MccI47, and demonstrated that the engineered strain significantly reduced the abundance of carbapenem-resistant Klebsiella pneumoniae in a clinical model without disrupting the resident microbiota. This study lays the foundation for using engineered live biotherapeutic products to selectively remove multidrug-resistant pathogens from the gastrointestinal tract.

GUT MICROBES (2022)

Article Microbiology

The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding method

Vanni Bucci, Doyle V. Ward, Shakti Bhattarai, Mayra Rojas-Correa, Ayan Purkayastha, Devon Holler, Ming Da Qu, William G. Mitchell, Jason Yang, Samuel Fountain, Abigail Zeamer, Catherine S. Forconi, Gavin Fujimori, Boaz Odwar, Caitlin Cawley, Ann M. Moormann, Mireya Wessolossky, Ana Maldonado-Contreras

Summary: SARS-CoV-2-positive patients exhibit gut and oral microbiome dysbiosis, which is associated with various aspects of COVID-19 disease. Gut microbiota, but not oral microbiota, is a reliable predictor of both COVID-19-related fatality and severity in hospitalized patients, with a higher predictive value than most clinical variables. Perturbations of the gut microbiota due to enteral feeding do not associate with species that were predictive of COVID-19 severity.

MSYSTEMS (2023)

Article Gastroenterology & Hepatology

The high prevalence of Clostridioides difficile among nursing home elders associates with a dysbiotic microbiome

John P. Haran, Doyle V. Ward, Shakti K. Bhattarai, Ethan Loew, Protiva Dutta, Amanda Higgins, Beth A. McCormick, Vanni Bucci

Summary: C. difficile is prevalent among elderly living in nursing homes, with dysbiotic gut microbiome being associated with its colonization. The use of proton pump inhibitors is linked to a lower prevalence of C. difficile.

GUT MICROBES (2021)

Article Microbiology

Draft Genome Sequence of Halomonas sp. Strain SL1, a Putative Polyhydroxyalkanoate-Producing Halophile

Tyler Rommeel, Kazuhiko Kurosawa, Lucy M. McCully, Mark W. Silby, Vanni Bucci, Christopher J. Brigham

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2019)

暂无数据